DexCom (DXCM) Tops Q2 EPS by 31c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $89.35 +1.61%
EPS Growth %: +9.8%
Financial Fact:
Net loss: -18.8M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +9.8%
Financial Fact:
Net loss: -18.8M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q2 EPS of $0.76, $0.31 better than the analyst estimate of $0.45. Revenue for the quarter came in at $59.5 million versus the consensus estimate of $551.27 million.
GUIDANCE:
DexCom sees FY2021 revenue of $2.35-2.4 billion, versus the consensus of $2.34 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
